Acknowledgements

• Fergus Lippi, David Salt, Mike Lipkin, David Whitley & Watkyn Wynn, University of Portsmouth, UK

• John Bradshaw, Daylight Chemical Information Systems, Cambridge, UK

• Roger Sayle, Metaphorics, Santa Fe, USA

• EPSRC

• Glaxo Wellcome (now GSK)

Previous slide

Next slide

Back to first slide

View graphic version